ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

New Ethics Rules Stir Anger, Disaffection at NIH, Scientists to Prepare a Legal Challenge.

February 11, 2005

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

January 25, 2013

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

NCI, ACS, Health Departments Launch ASSIST, Goal To Cut US Smoking Rate In Half By Yr 2000

October 11, 1991

In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List

February 7, 1992

Urgent Need For New Drugs To Treat Pre-Cancers: AACR.

March 1, 2002